JMP Securities Maintains Market Outperform on Vacasa, Lowers Price Target to $2.5
JMP Securities analyst Nicholas Jones maintains Vacasa (NASDAQ:VCSA) with a Market Outperform and lowers the price target from $3 to $2.5.
JMP Securities Maintains Market Outperform on SentinelOne, Lowers Price Target to $26
JMP Securities analyst Trevor Walsh maintains SentinelOne (NYSE:S) with a Market Outperform and lowers the price target from $36 to $26.
JMP Securities Maintains Market Outperform on Pardes Biosciences, Lowers Price Target to $5
JMP Securities analyst Roy Buchanan maintains Pardes Biosciences (NASDAQ:PRDS) with a Market Outperform and lowers the price target from $9 to $5.
Analyst Expectations for Jack Henry & Associates’s Future
Within the last quarter, Jack Henry & Associates (NASDAQ:JKHY) has observed the following analyst ratings: Bullish Somewhat Bullish…
The Latest Analyst Ratings for Illumina
Analysts have provided the following ratings for Illumina (NASDAQ:ILMN) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…
Analyst Expectations for Bandwidth’s Future
Bandwidth (NASDAQ:BAND) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
JMP Securities Reiterates Market Outperform on Arbor Realty Trust, Maintains $17.5 Price Target
JMP Securities analyst Steven Delaney reiterates Arbor Realty Trust (NYSE:ABR) with a Market Outperform and maintains $17.5 price target.
RBC Capital Reiterates Outperform on Range Resources, Maintains $40 Price Target
RBC Capital analyst Scott Hanold reiterates Range Resources (NYSE:RRC) with a Outperform and maintains $40 price target.
RBC Capital Reiterates Outperform on Magellan Midstream, Maintains $59 Price Target
RBC Capital analyst Elvira Scotto reiterates Magellan Midstream (NYSE:MMP) with a Outperform and maintains $59 price target.
RBC Capital Reiterates Outperform on Design Therapeutics, Maintains $24 Price Target
RBC Capital analyst Leonid Timashev reiterates Design Therapeutics (NASDAQ:DSGN) with a Outperform and maintains $24 price target.